• FirefoxInstall the new Firefox »
  •  Dow Down0.47% Nasdaq Down0.60%

    More On MRK.BA

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials


    Merck & Co. Inc. (MRK.BA)

    -Buenos Aires
    81.30 0.00(0.00%) Oct 8
    Add to Portfolio
    ProfileGet Profile for:
    Merck & Co. Inc.
    One Merck Drive
    PO Box 100
    Whitehouse Station, NJ 08889
    United States - Map
    Phone: 908-423-1000
    Website: http://www.merck.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Drug Manufacturers - Major
    Full Time Employees:70,000

    Business Summary 

    Merck & Co., Inc. provides health care solutions worldwide. The company offer therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus, HIV-1 infection, fungal infections, intra-abdominal infections, hypertension, arthritis and pain, inflammatory, osteoporosis, male pattern hair loss, and fertility diseases. It also offers neuromuscular blocking agents for use in surgery; anti-bacterial products for skin and skin structure infections; antidepressants; ophthalmic and cholesterol modification products; non-sedating antihistamine; and vaginal contraceptive implants. In addition, the company provides products to prevent chemotherapy-induced and post-operative nausea and vomiting; to treat brain tumors and melanoma; to prevent diseases caused by human papillomavirus, as well as vaccines for measles, mumps, rubella, varicella, chickenpox, shingles, rotavirus gastroenteritis, and pneumococcal diseases. Further, it offers animal health products, including antibiotic and anti-inflammatory drugs to treat infectious and respiratory diseases, fertility disorders, and pneumonia in cattle, horses, and swine; vaccines for poultry; parasiticide for sea lice in salmon; and antibiotics for, and vaccines against bacterial and viral disease in fish. Additionally, the company provides companion animal products, such as diabetes mellitus treatment drugs and vaccines for dogs and cats; ointments for acute and chronic otitis; anthelmintic products; chewable tablets to kill fleas and ticks in dogs; and products for protection against bites from fleas, ticks, mosquitoes, and sandflies. The company serves drug wholesalers and retailers, hospitals, government entities and agencies, physicians, physician distributors, veterinarians, distributors, and animal producers, as well as managed health care providers. The company was founded in 1891 and is headquartered in Kenilworth, New Jersey.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Merck & Co. Inc.

    Key Executives 
     PayExercised
    Mr. Kenneth C. Frazier , 60
    Chairman, Chief Exec. Officer and Pres
    3.35M0.00
    Dr. Roger M. Perlmutter M.D., Ph.D., 63
    Exec. VP and Pres of Merck Research Laboratories
    1.85M0.00
    Mr. Adam H. Schechter , 50
    Pres of Global Human Health and Exec. VP
    1.81M0.00
    Mr. Robert M. Davis J.D., 48
    Chief Financial Officer and Exec. VP
    N/AN/A
    Ms. Rita A. Karachun , 51
    Principal Accounting Officer, Sr. VP of Fin. and Global Controller
    N/AN/A
    Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in ARS.